Fennec Pharmaceuticals Inc.
US ˙ NasdaqCM ˙ CA31447P1009

SecurityFENC / Fennec Pharmaceuticals Inc.
InstitutionNorthern Trust Corp
Latest Disclosed Ownership152,123 shares
Latest Disclosed Value $ 935,556
Northern Trust Corp reports 35.71% increase in ownership of FENC / Fennec Pharmaceuticals Inc.

On May 14, 2026 - Northern Trust Corp filed a 13F-HR form disclosing ownership of 152,123 shares of Fennec Pharmaceuticals Inc. (US:FENC) valued at $935,556 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 17, 2026 disclosing 112,092 shares of Fennec Pharmaceuticals Inc.. This represents a change in shares of 35.71% during the quarter. The current value of the position is $1,393,447 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-05-14 2026-03-31 13F FENNEC PHARMACEUTICALS COM 31447P100 152,123 40,031 35.71 936 8.34 0.0001
2026-02-17 2025-12-31 13F FENNEC PHARMACEUTICALS COM 31447P100 112,092 -18,461 -14.14 863 -29.32 0.0001
2025-11-14 2025-09-30 13F FENNEC PHARMACEUTICALS COM 31447P100 130,553 -919 -0.70 1,222 11.92 0.0002
2025-08-13 2025-06-30 13F FENNEC PHARMACEUTICALS COM 31447P100 131,472 -6,903 -4.99 1,091 29.57 0.0002
2025-05-13 2025-03-31 13F FENNEC PHARMACEUTICALS COM 31447P100 138,375 1,620 1.18 843 -2.55 0.0001
2025-02-14 2024-12-31 13F FENNEC PHARMACEUTICALS COM 31447P100 136,755 -2,976 -2.13 864 23.78 0.0001
2024-11-13 2024-09-30 13F FENNEC PHARMACEUTICALS COM 31447P100 139,731 33,332 31.33 699 7.38 0.0001
2024-08-14 2024-06-30 13F FENNEC PHARMACEUTICALS COM 31447P100 106,399 -7,669 -6.72 650 -48.74 0.0001
2024-05-14 2024-03-31 13F FENNEC PHARMACEUTICALS COM 31447P100 114,068 2,308 2.07 1,268 1.20 0.0002
2024-02-13 2023-12-31 13F FENNEC PHARMACEUTICALS COM 31447P100 111,760 897 0.81 1,254 50.60 0.0002
2023-11-13 2023-09-30 13F FENNEC PHARMACEUTICALS COM 31447P100 110,863 -3,620 -3.16 833 -17.62 0.0002
2023-08-11 2023-06-30 13F FENNEC PHARMACEUTICALS COM 31447P100 114,483 114,483 1,011 0.0002
2021-08-13 2021-06-30 13F FENNEC PHARMACEUTICALS COM 31447P100 0 -182,107 -100.00 0 -100.00
2021-05-12 2021-03-31 13F FENNEC PHARMACEUTICALS COM 31447P100 182,107 -21,892 -10.73 1,131 -25.59 0.0002
2021-02-11 2020-12-31 13F FENNEC PHARMACEUTICALS COM 31447P100 203,999 -2,635 -1.28 1,520 21.41 0.0003
2020-11-16 2020-09-30 13F FENNEC PHARMACEUTICALS COM 31447P100 206,634 -10,226 -4.72 1,252 -30.87 0.0003
2020-08-14 2020-06-30 13F FENNEC PHARMACEUTICALS COM 31447P100 216,860 216,860 1,811 0.0004
2019-11-13 2019-09-30 13F FENNEC PHARMACEUTICALS COM 31447P100 0 -96,972 -100.00 0 -100.00
2019-08-13 2019-06-30 13F FENNEC PHARMACEUTICALS COM 31447P100 96,972 -5,105 -5.00 388 -21.62 0.0001
2019-05-13 2019-03-31 13F FENNEC PHARMACEUTICALS COM 31447P100 102,077 220 0.22 495 -23.85 0.0001
2019-02-12 2018-12-31 13F FENNEC PHARMACEUTICALS COM 31447P100 101,857 -228 -0.22 650 -22.34 0.0002
2018-11-14 2018-09-30 13F FENNEC PHARMACEUTICALS COM 31447P100 102,085 753 0.74 837 -20.89 0.0002
2018-09-18 2018-06-30 13F/A-1 FENNEC PHARMACEUTICALS COM 31447P100 101,332 101,332 1,058 0.0003
2018-08-14 2018-06-30 13F FENNEC PHARMACEUTICALS COM 31447P100 101,332 1,058 0.0003
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.